LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Science
• Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

article, pubmed, google, scholar, cas, cancer, bcl, abt, lymphoma, cell, expression, apoptosis, family, multiple, res, inhibitor, vivo, bcell, resistance, cells, leukemia, chemotherapy, ackler, etoposide, blood, hematologic, myeloma, vitro, rituximab, bortezomib, diffuse, large, proteins, chronic, privacy, cookies, content, response, chemotherapeutic, scott, mitten, vincristine, activity, therapy, access, lymphocytic, ther, information, publish, research,

Topics {✒️}

month download article/chapter chronic lymphocytic leukaemia nonpeptidic small-molecule inhibitor rituximab-resistant lymphoma clones b-cell lymphoma apoptosis-related genes bcl2 myeloid cell leukemia-1 cancer therapy gov/statfacts/html/nhl noxa-mediated lipid peroxidation indolent b-cell drug targets small-molecule inhibitor article cancer chemotherapy acute myeloid leukemia tumor cell clearance bcl-2-related genes full article pdf bcl2 antagonist abt-737 related subjects privacy choices/manage cookies altered cell signaling kill lymphoma cells bcl-xl potentiates chemotherapy resistance resulting bh3 mimetic abt-263 bh3-mimetic abt-737 bh3 mimetic abt-737 bcl-2 family genes chemotherapy improves response bcl-2 family members mimetic abt-737 synergizes multidrug resistance phenotype hodgkin lymphoma [top acute lymphoblastic leukemia //seer bcl-2 family proteins article ackler fresh myeloma cells national cancer institute shoemaker ar hematologic tumor models rituximab-mediated apoptosis european economic area tumor response rates rapamycin act cooperatively sequester prodeath bim death receptor pathway dose-effect relationships hernandez-ilizaliturri fj

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
         description:This study was designed to test the ability of the Bcl-2 family inhibitor ABT-263 to potentiate commonly used chemotherapeutic agents and regimens in hematologic tumor models. Models of B-cell lymphoma and multiple myeloma were tested in vitro and in vivo with ABT-263 in combination with standard chemotherapeutic regimens, including VAP, CHOP and R-CHOP, as well as single cytotoxic agents including etoposide, rituximab, bortezomib and cyclophosphamide. Alterations in Bcl-2 family member expression patterns were analyzed to define mechanisms of potentiation. ABT-263 was additive with etoposide, vincristine and VAP in vitro in the diffuse large B-cell lymphoma line (DLBCL) DoHH-2, while rituximab potentiated its activity in SuDHL-4. Bortezomib strongly synergized with ABT-263 in the mantle cell lymphoma line Granta 519. Treatment of DoHH-2 with etoposide was associated with an increase in Puma expression, while bortezomib upregulated Noxa expression in Granta 519. Combination of ABT-263 with cytotoxic agents demonstrated superior tumor growth inhibition and delay in multiple models versus cytotoxic therapy alone, along with significant improvements in tumor response rates. Inhibition of the Bcl-2 family of proteins by ABT-263 enhances the cytotoxicity of multiple chemotherapeutics in hematologic tumors and represents a promising addition to the therapeutic arsenal for treatment of these diseases.
         datePublished:2010-01-23T00:00:00Z
         dateModified:2010-01-23T00:00:00Z
         pageStart:869
         pageEnd:880
         sameAs:https://doi.org/10.1007/s00280-009-1232-1
         keywords:
            ABT-263
            Bcl-2
            Lymphoma
            Myeloma
            Apoptosis
            Oncology
            Pharmacology/Toxicology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig4_HTML.gif
         isPartOf:
            name:Cancer Chemotherapy and Pharmacology
            issn:
               1432-0843
               0344-5704
            volumeNumber:66
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Scott Ackler
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
                     name:
                     address:
                        name:Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Michael J. Mitten
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kelly Foster
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anatol Oleksijew
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marion Refici
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephen K. Tahir
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu Xiao
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christin Tse
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David J. Frost
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephen W. Fesik
               affiliation:
                     name:Vanderbilt University School of Medicine
                     address:
                        name:Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Saul H. Rosenberg
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Steven W. Elmore
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alexander R. Shoemaker
               affiliation:
                     name:Abbott Laboratories
                     address:
                        name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
      description:This study was designed to test the ability of the Bcl-2 family inhibitor ABT-263 to potentiate commonly used chemotherapeutic agents and regimens in hematologic tumor models. Models of B-cell lymphoma and multiple myeloma were tested in vitro and in vivo with ABT-263 in combination with standard chemotherapeutic regimens, including VAP, CHOP and R-CHOP, as well as single cytotoxic agents including etoposide, rituximab, bortezomib and cyclophosphamide. Alterations in Bcl-2 family member expression patterns were analyzed to define mechanisms of potentiation. ABT-263 was additive with etoposide, vincristine and VAP in vitro in the diffuse large B-cell lymphoma line (DLBCL) DoHH-2, while rituximab potentiated its activity in SuDHL-4. Bortezomib strongly synergized with ABT-263 in the mantle cell lymphoma line Granta 519. Treatment of DoHH-2 with etoposide was associated with an increase in Puma expression, while bortezomib upregulated Noxa expression in Granta 519. Combination of ABT-263 with cytotoxic agents demonstrated superior tumor growth inhibition and delay in multiple models versus cytotoxic therapy alone, along with significant improvements in tumor response rates. Inhibition of the Bcl-2 family of proteins by ABT-263 enhances the cytotoxicity of multiple chemotherapeutics in hematologic tumors and represents a promising addition to the therapeutic arsenal for treatment of these diseases.
      datePublished:2010-01-23T00:00:00Z
      dateModified:2010-01-23T00:00:00Z
      pageStart:869
      pageEnd:880
      sameAs:https://doi.org/10.1007/s00280-009-1232-1
      keywords:
         ABT-263
         Bcl-2
         Lymphoma
         Myeloma
         Apoptosis
         Oncology
         Pharmacology/Toxicology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_Fig4_HTML.gif
      isPartOf:
         name:Cancer Chemotherapy and Pharmacology
         issn:
            1432-0843
            0344-5704
         volumeNumber:66
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Scott Ackler
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
                  name:
                  address:
                     name:Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Michael J. Mitten
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kelly Foster
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anatol Oleksijew
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marion Refici
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephen K. Tahir
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu Xiao
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christin Tse
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David J. Frost
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephen W. Fesik
            affiliation:
                  name:Vanderbilt University School of Medicine
                  address:
                     name:Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Saul H. Rosenberg
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Steven W. Elmore
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alexander R. Shoemaker
            affiliation:
                  name:Abbott Laboratories
                  address:
                     name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Chemotherapy and Pharmacology
      issn:
         1432-0843
         0344-5704
      volumeNumber:66
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
      name:
      address:
         name:Abbott Park, USA
         type:PostalAddress
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
      name:Vanderbilt University School of Medicine
      address:
         name:Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, USA
         type:PostalAddress
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
      name:Abbott Laboratories
      address:
         name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Scott Ackler
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
            name:
            address:
               name:Abbott Park, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Michael J. Mitten
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
      name:Kelly Foster
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
      name:Anatol Oleksijew
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
      name:Marion Refici
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
      name:Stephen K. Tahir
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
      name:Yu Xiao
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
      name:Christin Tse
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
      name:David J. Frost
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
      name:Stephen W. Fesik
      affiliation:
            name:Vanderbilt University School of Medicine
            address:
               name:Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, USA
               type:PostalAddress
            type:Organization
      name:Saul H. Rosenberg
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
      name:Steven W. Elmore
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
      name:Alexander R. Shoemaker
      affiliation:
            name:Abbott Laboratories
            address:
               name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
      name:Abbott Park, USA
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
      name:Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, USA
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
      name:Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(171)

• https://www.springernature.com/gp/authors's financial summary
• https://link.springernature.com/home/'s revenue stream
• What is the monthly revenue of https://order.springer.com/public/cart?
• How much profit is https://submission.springernature.com/new-submission/280/3 making per month?
• How much does https://www.springernature.com/gp/librarians/licensing/agc/journals pull in?
• How much does http://seer.cancer.gov/statfacts/html/nhl.html make?
• https://doi.org/10.2165%2F00003495-200666060-00005's revenue stream
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16706552's earnings
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Rituximab%3A%20a%20review%20of%20its%20use%20in%20non-Hodgkin%E2%80%99s%20lymphoma%20and%20chronic%20lymphocytic%20leukaemia&journal=Drugs&doi=10.2165%2F00003495-200666060-00005&volume=66&pages=791-820&publication_year=2006&author=Cvetkovic%2CRS&author=Perry%2CCM is on a monthly basis
• How much profit does https://doi.org/10.1158%2F1078-0432.CCR-07-2218 generate?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18347166 generate?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Proteasome%20inhibitors%20in%20cancer%20therapy%3A%20lessons%20from%20the%20first%20decade&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-2218&volume=14&pages=1649-1657&publication_year=2008&author=Orlowski%2CRZ&author=Kuhn%2CDJ?
• How much money does https://doi.org/10.2146%2Fajhp070272 make?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18574011?
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Bortezomib%3A%20a%20novel%20chemotherapeutic%20agent%20for%20hematologic%20malignancies&journal=Am%20J%20Health%20Syst%20Pharm&doi=10.2146%2Fajhp070272&volume=65&pages=1221-1231&publication_year=2008&author=Utecht%2CKN&author=Kolesar%2CJ?
• What's the financial gain of https://doi.org/10.1532%2FIJH97.04110?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15540893 income
• How much profit does http://scholar.google.com/scholar_lookup?&title=Bcl-2-related%20genes%20in%20lymphoid%20neoplasia&journal=Int%20J%20Hematol&doi=10.1532%2FIJH97.04110&volume=80&pages=205-209&publication_year=2004&author=Wei%2CMC generate?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9408956?
• How much does http://scholar.google.com/scholar_lookup?&title=Bcl-2%20family%20proteins%3A%20regulators%20of%20apoptosis%20and%20chemoresistance%20in%20hematologic%20malignancies&journal=Semin%20Hematol&volume=34&pages=9-19&publication_year=1997&author=Reed%2CJC gross monthly?
• How profitable is https://doi.org/10.1126%2Fscience.6093263?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6093263
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Cloning%20of%20the%20chromosome%20breakpoint%20of%20neoplastic%20B%20cells%20with%20the%20t%2814%3B18%29%20chromosome%20translocation&journal=Science&doi=10.1126%2Fscience.6093263&volume=226&pages=1097-1099&publication_year=1984&author=Tsujimoto%2CY&author=Finger%2CLR&author=Yunis%2CJ&author=Nowell%2CPC&author=Croce%2CCM
• What's the monthly income of https://doi.org/10.1002%2Fajh.10139?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12210808?
• How much does http://scholar.google.com/scholar_lookup?&title=Bcl-2%20family%20of%20proteins%20in%20indolent%20B-cell%20non-Hodgkin%E2%80%99s%20lymphoma%3A%20study%20of%20116%20cases&journal=Am%20J%20Hematol&doi=10.1002%2Fajh.10139&volume=70&pages=278-282&publication_year=2002&author=Agarwal%2CB&author=Naresh%2CKN net monthly?
• How much income is https://doi.org/10.1038%2Fsj.leu.2401168 earning monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9823959 earn?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20Bcl-2%20family%20of%20proteins%20in%20fresh%20myeloma%20cells&journal=Leukemia&doi=10.1038%2Fsj.leu.2401168&volume=12&pages=1817-1820&publication_year=1998&author=Harada%2CN&author=Hata%2CH&author=Yoshida%2CM
• See how much https://doi.org/10.1038%2F35000501 makes per month
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10676951?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Distinct%20types%20of%20diffuse%20large%20B-cell%20lymphoma%20identified%20by%20gene%20expression%20profiling&journal=Nature&doi=10.1038%2F35000501&volume=403&pages=503-511&publication_year=2000&author=Alizadeh%2CAA&author=Eisen%2CMB&author=Davis%2CRE bring in?
• What's the financial gain of https://doi.org/10.1111%2Fj.1365-2567.2005.02117.x?
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15804279
• How much does http://scholar.google.com/scholar_lookup?&title=Bodyguards%20and%20assassins%3A%20Bcl-2%20family%20proteins%20and%20apoptosis%20control%20in%20chronic%20lymphocytic%20leukaemia&journal=Immunology&doi=10.1111%2Fj.1365-2567.2005.02117.x&volume=114&pages=441-449&publication_year=2005&author=Packham%2CG&author=Stevenson%2CFK rake in every month?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9443402 is on a monthly basis
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Bcl-X%20expression%20in%20multiple%20myeloma%3A%20possible%20indicator%20of%20chemoresistance&journal=Cancer%20Res&volume=58&pages=256-262&publication_year=1998&author=Tu%2CY&author=Renner%2CS&author=Xu%2CF?
• https://doi.org/10.1023%2FA%3A1007056727876's revenue stream
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10839193?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Differential%20responses%20of%20Bcl-2%20family%20genes%20to%20etoposide%20in%20chronic%20myeloid%20leukemia%20K562%20cells&journal=Mol%20Cell%20Biochem&doi=10.1023%2FA%3A1007056727876&volume=206&pages=43-50&publication_year=2000&author=Fukumi%2CS&author=Horiguchi-Yamada%2CJ&author=Nakada%2CS&author=Nagai%2CM&author=Ohno%2CT&author=Yamada%2CH?
• How much does https://doi.org/10.1196%2Fannals.1378.009 pull in?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17384250?
• How much money does http://scholar.google.com/scholar_lookup?&title=Alterations%20in%20mRNA%20expression%20of%20apoptosis-related%20genes%20BCL2%2C%20BAX%2C%20FAS%2C%20caspase-3%2C%20and%20the%20novel%20member%20BCL2L12%20after%20treatment%20of%20human%20leukemic%20cell%20line%20HL60%20with%20the%20antineoplastic%20agent%20etoposide&journal=Ann%20N%20Y%20Acad%20Sci&doi=10.1196%2Fannals.1378.009&volume=1090&pages=89-97&publication_year=2006&author=Floros%2CKV&author=Thomadaki%2CH&author=Florou%2CD&author=Talieri%2CM&author=Scorilas%2CA make?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10500812 make?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Two%20distinct%20modes%20of%20oncoprotein%20expression%20during%20apoptosis%20resistance%20in%20vincristine%20and%20daunorubicin%20multidrug-resistant%20HL60%20cells&journal=Adv%20Exp%20Med%20Biol&volume=457&pages=365-381&publication_year=1999&author=Belhoussine%2CR&author=Morjani%2CH&author=Gillet%2CR&author=Palissot%2CV&author=Manfait%2CM
• Monthly income for https://doi.org/10.1182%2Fblood-2007-08-110445
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18160669?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Bortezomib%20blocks%20Bax%20degradation%20in%20malignant%20B%20cells%20during%20treatment%20with%20TRAIL&journal=Blood&doi=10.1182%2Fblood-2007-08-110445&volume=111&pages=2797-2805&publication_year=2008&author=Liu%2CFT&author=Agrawal%2CSG&author=Gribben%2CJG
• What's the financial outcome of https://doi.org/10.1158%2F0008-5472.CAN-06-4322?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17545623?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Noxa%20up-regulation%20and%20Mcl-1%20cleavage%20are%20associated%20to%20apoptosis%20induction%20by%20bortezomib%20in%20multiple%20myeloma&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-4322&volume=67&pages=5418-5424&publication_year=2007&author=Gomez-Bougie%2CP&author=Wuilleme-Toumi%2CS&author=Menoret%2CE
• How much profit does https://doi.org/10.1182%2Fblood.V99.3.1038 make?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11807010?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=The%20mechanism%20of%20tumor%20cell%20clearance%20by%20rituximab%20in%20vivo%20in%20patients%20with%20B-cell%20chronic%20lymphocytic%20leukemia%3A%20evidence%20of%20caspase%20activation%20and%20apoptosis%20induction&journal=Blood&doi=10.1182%2Fblood.V99.3.1038&volume=99&pages=1038-1043&publication_year=2002&author=Byrd%2CJC&author=Kitada%2CS&author=Flinn%2CIW?
• https://doi.org/10.1158%2F0008-5472.CAN-07-5836's total income per month
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18451170 generate monthly?
• What's the income of http://scholar.google.com/scholar_lookup?&title=ABT-263%3A%20a%20potent%20and%20orally%20bioavailable%20Bcl-2%20family%20inhibitor&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-07-5836&volume=68&pages=3421-3428&publication_year=2008&author=Tse%2CC&author=Shoemaker%2CAR&author=Adickes%2CJ?
• What's the income of https://doi.org/10.1158%2F1535-7163.MCT-08-0268?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18852130?
• Get to know http://scholar.google.com/scholar_lookup?&title=ABT-263%20and%20rapamycin%20act%20cooperatively%20to%20kill%20lymphoma%20cells%20in%20vitro%20and%20in%20vivo&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-08-0268&volume=7&pages=3265-3274&publication_year=2008&author=Ackler%2CS&author=Xiao%2CY&author=Mitten%2CMJ's earnings
• How much money does https://doi.org/10.1002%2Fpbc.21433 make?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18085673?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Initial%20testing%20%28stage%201%29%20of%20the%20BH3%20mimetic%20ABT-263%20by%20the%20pediatric%20preclinical%20testing%20program&journal=Pediatr%20Blood%20Cancer&doi=10.1002%2Fpbc.21433&volume=50&pages=1181-1189&publication_year=2008&author=Lock%2CR&author=Carol%2CH&author=Houghton%2CPJ is on a monthly basis
• How much profit is https://doi.org/10.1172%2FJCI28281 making per month?
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17200714
• Revenue of http://scholar.google.com/scholar_lookup?&title=Chronic%20lymphocytic%20leukemia%20requires%20BCL2%20to%20sequester%20prodeath%20BIM%2C%20explaining%20sensitivity%20to%20BCL2%20antagonist%20ABT-737&journal=J%20Clin%20Invest&doi=10.1172%2FJCI28281&volume=117&pages=112-121&publication_year=2007&author=Del%20Gaizo%20Moore%2CV&author=Brown%2CJR&author=Certo%2CM&author=Love%2CTM&author=Novina%2CCD&author=Letai%2CA
• https://doi.org/10.1182%2Fblood-2007-12-130781 income
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18591385?
• How much does http://scholar.google.com/scholar_lookup?&title=The%20BH3-only%20mimetic%20ABT-737%20synergizes%20the%20antineoplastic%20activity%20of%20proteasome%20inhibitors%20in%20lymphoid%20malignancies&journal=Blood&doi=10.1182%2Fblood-2007-12-130781&volume=112&pages=2906-2916&publication_year=2008&author=Paoluzzi%2CL&author=Gonen%2CM&author=Bhagat%2CG pull in monthly?
• Check the income stats for https://doi.org/10.1182%2Fblood-2007-03-080325
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17536015 making per month?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Activity%20of%20vincristine%2C%20L-ASP%2C%20and%20dexamethasone%20against%20acute%20lymphoblastic%20leukemia%20is%20enhanced%20by%20the%20BH3-mimetic%20ABT-737%20in%20vitro%20and%20in%20vivo&journal=Blood&doi=10.1182%2Fblood-2007-03-080325&volume=110&pages=2057-2066&publication_year=2007&author=Kang%2CMH&author=Kang%2CYH&author=Szymanska%2CB?
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15657349
• http://scholar.google.com/scholar_lookup?&title=Preclinical%20studies%20of%20a%20nonpeptidic%20small-molecule%20inhibitor%20of%20Bcl-2%20and%20Bcl-xL%20%5B%28-%29-gossypol%5D%20against%20diffuse%20large%20cell%20lymphoma&journal=Mol%20Cancer%20Ther&volume=4&pages=13-21&publication_year=2005&author=Mohammad%2CRM&author=Wang%2CS&author=Aboukameel%2CA's financial summary
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17277134?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Fas%20receptor%20clustering%20and%20involvement%20of%20the%20death%20receptor%20pathway%20in%20rituximab-mediated%20apoptosis%20with%20concomitant%20sensitization%20of%20lymphoma%20B%20cells%20to%20fas-induced%20apoptosis&journal=J%20Immunol&volume=178&pages=2287-2295&publication_year=2007&author=Stel%2CAJ&author=Ten%20Cate%2CB&author=Jacobs%2CS?
• What's the financial outcome of https://doi.org/10.1016%2F0065-2571%2884%2990007-4?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6382953
• How much does http://scholar.google.com/scholar_lookup?&title=Quantitative%20analysis%20of%20dose-effect%20relationships%3A%20the%20combined%20effects%20of%20multiple%20drugs%20or%20enzyme%20inhibitors&journal=Adv%20Enzyme%20Regul&doi=10.1016%2F0065-2571%2884%2990007-4&volume=22&pages=27-55&publication_year=1984&author=Chou%2CTC&author=Talalay%2CP rake in every month?
• https://doi.org/10.1158%2F0008-5472.CAN-06-0367 income
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16951189's earnings
• How much profit does http://scholar.google.com/scholar_lookup?&title=A%20small-molecule%20inhibitor%20of%20Bcl-xL%20potentiates%20the%20activity%20of%20cytotoxic%20drugs%20in%20vitro%20and%20in%20vivo&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-0367&volume=66&pages=8731-8739&publication_year=2006&author=Shoemaker%2CAR&author=Oleksijew%2CA&author=Bauch%2CJ make?
• How much income is https://doi.org/10.1016%2F0163-7258%2888%2990004-6 earning monthly?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3290910 make?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Metabolism%20of%20oxazaphosphorines&journal=Pharmacol%20Ther&doi=10.1016%2F0163-7258%2888%2990004-6&volume=37&pages=301-355&publication_year=1988&author=Sladek%2CNE?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14707277?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Genistein%20sensitizes%20diffuse%20large%20cell%20lymphoma%20to%20CHOP%20%28cyclophosphamide%2C%20doxorubicin%2C%20vincristine%2C%20prednisone%29%20chemotherapy&journal=Mol%20Cancer%20Ther&volume=2&pages=1361-1368&publication_year=2003&author=Mohammad%2CRM&author=Al-Katib%2CA&author=Aboukameel%2CA&author=Doerge%2CDR&author=Sarkar%2CF&author=Kucuk%2CO
• What's the financial gain of https://doi.org/10.2165%2F00003495-199958003-00006?
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10711840 making per month?
• How much does http://scholar.google.com/scholar_lookup?&title=Oral%20etoposide%20in%20lymphoma&journal=Drugs&doi=10.2165%2F00003495-199958003-00006&volume=58&issue=Suppl%203&pages=35-41&publication_year=1999&author=Greco%2CFA generate monthly?
• How much does https://doi.org/10.1158%2F0008-5472.CAN-06-2203 pull in monthly?
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17283153?
• How much does http://scholar.google.com/scholar_lookup?&title=Influence%20of%20Bcl-2%20family%20members%20on%20the%20cellular%20response%20of%20small-cell%20lung%20cancer%20cell%20lines%20to%20ABT-737&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-2203&volume=67&pages=1176-1183&publication_year=2007&author=Tahir%2CSK&author=Yang%2CX&author=Anderson%2CMG rake in every month?
• How much does https://doi.org/10.1038%2Fsj.onc.1210166 rake in every month?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17173063?
• Get to know http://scholar.google.com/scholar_lookup?&title=%E2%80%98Seed%E2%80%99%20analysis%20of%20off-target%20siRNAs%20reveals%20an%20essential%20role%20of%20Mcl-1%20in%20resistance%20to%20the%20small-molecule%20Bcl-2%2FBcl-xL%20inhibitor%20ABT-737&journal=Oncogene&doi=10.1038%2Fsj.onc.1210166&volume=26&pages=3972-3979&publication_year=2007&author=Lin%2CX&author=Morgan-Lappe%2CS&author=Huang%2CX's earnings
• What's the financial gain of https://doi.org/10.1016%2Fj.ccr.2006.10.006?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17097560 bring in?
• How much income is http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20apoptosis%20sensitivity%20and%20resistance%20to%20the%20BH3%20mimetic%20ABT-737%20in%20acute%20myeloid%20leukemia&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2006.10.006&volume=10&pages=375-388&publication_year=2006&author=Konopleva%2CM&author=Contractor%2CR&author=Tsao%2CT earning monthly?
• How much does https://doi.org/10.1016%2Fj.ccr.2006.08.027 net monthly?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17097561 make?
• How much does http://scholar.google.com/scholar_lookup?&title=The%20BH3%20mimetic%20ABT-737%20targets%20selective%20Bcl-2%20proteins%20and%20efficiently%20induces%20apoptosis%20via%20Bak%2FBax%20if%20Mcl-1%20is%20neutralized&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2006.08.027&volume=10&pages=389-399&publication_year=2006&author=Delft%2CMF&author=Wei%2CAH&author=Mason%2CKD rake in every month?
• https://doi.org/10.1517%2F14728222.11.3.363's financial summary
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17298294 pull in monthly?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Myeloid%20cell%20leukemia-1%20as%20a%20therapeutic%20target&journal=Expert%20Opin%20Ther%20Targets&doi=10.1517%2F14728222.11.3.363&volume=11&pages=363-373&publication_year=2007&author=Mandelin%2CAM&author=Pope%2CRM?
• Profit of https://doi.org/10.1093%2Fcarcin%2Fbgp165
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19578044 earns monthly
• Profit of http://scholar.google.com/scholar_lookup?&title=Cisplatin%20overcomes%20Bcl-2-mediated%20resistance%20to%20apoptosis%20via%20preferential%20engagement%20of%20Bak%3A%20critical%20role%20of%20Noxa-mediated%20lipid%20peroxidation&journal=Carcinogenesis&doi=10.1093%2Fcarcin%2Fbgp165&volume=30&pages=1517-1527&publication_year=2009&author=Kutuk%2CO&author=Arisan%2CED&author=Tezil%2CT&author=Shoshan%2CMC&author=Basaga%2CH
• https://doi.org/10.1158%2F1078-0432.CCR-07-1255's revenue stream
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18316580
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20to%20rituximab%20is%20associated%20with%20chemotherapy%20resistance%20resulting%20from%20decreased%20Bax%20and%20Bak%20expression&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1255&volume=14&pages=1550-1560&publication_year=2008&author=Olejniczak%2CSH&author=Hernandez-Ilizaliturri%2CFJ&author=Clements%2CJL&author=Czuczman%2CMS is on a monthly basis
• What is the monthly revenue of https://doi.org/10.1158%2F0008-5472.CAN-06-2184?
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17283164 earning monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Development%20of%20rituximab-resistant%20lymphoma%20clones%20with%20altered%20cell%20signaling%20and%20cross-resistance%20to%20chemotherapy&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-2184&volume=67&pages=1270-1281&publication_year=2007&author=Jazirehi%2CAR&author=Vega%2CMI&author=Bonavida%2CB make?
• See how much https://doi.org/10.1038%2Fsj.bjc.6603762 makes per month
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17473827's total income per month
• What's the income of http://scholar.google.com/scholar_lookup?&title=Bcl-2%20expression%20in%20rituximab%20refractory%20cutaneous%20B-cell%20lymphoma&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6603762&volume=96&pages=1540-1543&publication_year=2007&author=Wobser%2CM&author=Voigt%2CH&author=Eggert%2CAO?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11156256
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=The%20addition%20of%20bryostatin%201%20to%20cyclophosphamide%2C%20doxorubicin%2C%20vincristine%2C%20and%20prednisone%20%28CHOP%29%20chemotherapy%20improves%20response%20in%20a%20CHOP-resistant%20human%20diffuse%20large%20cell%20lymphoma%20xenograft%20model&journal=Clin%20Cancer%20Res&volume=6&pages=4950-4956&publication_year=2000&author=Mohammad%2CRM&author=Wall%2CNR&author=Dutcher%2CJA&author=Al-Katib%2CAM?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8172820 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20chemoresistance%20by%20the%20Bcl-2%20oncoprotein%20in%20non-Hodgkin%E2%80%99s%20lymphoma%20and%20lymphocytic%20leukemia%20cell%20lines&journal=Ann%20Oncol&volume=5&issue=Suppl%201&pages=61-65&publication_year=1994&author=Reed%2CJC&author=Kitada%2CS&author=Takayama%2CS&author=Miyashita%2CT bring in each month?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7655019
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20Bcl-xL%20can%20confer%20a%20multidrug%20resistance%20phenotype&journal=Blood&volume=86&pages=1903-1910&publication_year=1995&author=Minn%2CAJ&author=Rudin%2CCM&author=Boise%2CLH&author=Thompson%2CCB produce monthly?
• What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8781438 each month?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Upregulated%20expression%20of%20BCL-2%20in%20multiple%20myeloma%20cells%20induced%20by%20exposure%20to%20doxorubicin%2C%20etoposide%2C%20and%20hydrogen%20peroxide&journal=Blood&volume=88&pages=1805-1812&publication_year=1996&author=Tu%2CY&author=Xu%2CFH&author=Liu%2CJ
• How much profit does https://citation-needed.springer.com/v2/references/10.1007/s00280-009-1232-1?format=refman&flavour=references generate?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Scott%20Ackler's financial summary
• What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Scott%20Ackler%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michael%20J.%20Mitten's financial summary
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michael%20J.%20Mitten%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kelly%20Foster gross monthly?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kelly%20Foster%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anatol%20Oleksijew make?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anatol%20Oleksijew%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marion%20Refici pull in?
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marion%20Refici%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Stephen%20K.%20Tahir is on a monthly basis
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Stephen%20K.%20Tahir%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yu%20Xiao
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yu%20Xiao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
• Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christin%20Tse
• Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christin%20Tse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=David%20J.%20Frost earning monthly?
• How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22David%20J.%20Frost%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
• Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Stephen%20W.%20Fesik
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Stephen%20W.%20Fesik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Saul%20H.%20Rosenberg have?
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Saul%20H.%20Rosenberg%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Steven%20W.%20Elmore
• How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Steven%20W.%20Elmore%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
• Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alexander%20R.%20Shoemaker
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alexander%20R.%20Shoemaker%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• How much does https://static-content.springer.com/esm/art%3A10.1007%2Fs00280-009-1232-1/MediaObjects/280_2009_1232_MOESM1_ESM.pdf bring in each month?
• Revenue of https://s100.copyright.com/AppDispatchServlet?title=The%20Bcl-2%20inhibitor%20ABT-263%20enhances%20the%20response%20of%20multiple%20chemotherapeutic%20regimens%20in%20hematologic%20tumors%20in%20vivo&author=Scott%20Ackler%20et%20al&contentID=10.1007%2Fs00280-009-1232-1©right=Springer-Verlag&publication=0344-5704&publicationDate=2010-01-23&publisherName=SpringerNature&orderBeanReset=true
• See how much https://citation-needed.springer.com/v2/references/10.1007/s00280-009-1232-1?format=refman&flavour=citation makes per month
• What are the total earnings of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
• What's the financial intake of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
• What's the financial intake of https://www.springernature.com/gp/products?
• What are the earnings of https://www.springernature.com/gp/librarians?
• What's the income generated by https://www.springernature.com/gp/societies each month?
• What's the income generated by https://www.springernature.com/gp/partners each month?
• What's the profit of https://www.springer.com/?
• https://www.nature.com/'s total income per month
• How much profit does https://www.biomedcentral.com/ generate?
• What's the monthly money flow for https://www.palgrave.com/?
• How much revenue does https://www.apress.com/ generate?
• How much does https://www.springernature.com/gp/legal/ccpa generate monthly?
• How much does https://www.springernature.com/gp/info/accessibility earn?
• Financial intake of https://support.springernature.com/en/support/home
• How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations rake in every month?
• What's the income generated by https://www.springernature.com/ each month?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref